Mazindol and lidocaine are antinociceptives in the mouse formalin model: involvement of dopamine receptor

作者: Alvorita L Bittencourt , Reinaldo N Takahashi

DOI: 10.1016/S0014-2999(97)00182-9

关键词:

摘要: The antinociceptive potential of mazindol, an anorectic drug, and lidocaine, amide-type local anesthetic, were investigated in the mouse formalin test with concurrent motor function assessment. In addition, role dopamine opioid receptors mediation action these drugs was examined. i.p. injection mazindol (1.25–10 mg/kg) lidocaine (10–30 induced significant responses both phases test. Cocaine (20 mg/kg, i.p.), used as positive control, also inhibited pain caused by formalin. Haloperidol (0.2 sulpiride (5 a D2 receptor antagonist, reduced actions cocaine, while SCH 23390, R(+)-7-chloro 8-hydroxy-3methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3 benzazepine (0.03 D1 did not affect responses. Only antinociception associated reversed naloxone (2 i.p.). same pretreatments failed to modify lidocaine-induced antinociception. drug conditions this study reveal any impairment rotarod These observations suggest involvement dopaminergic mechanisms, mainly via receptors, test, but nature mechanisms involved remains unsolved.

参考文章(24)
S E Robinson, J H Graham, J R Maher, The effect of cocaine and other local anesthetics on central dopaminergic neurotransmission. Journal of Pharmacology and Experimental Therapeutics. ,vol. 274, pp. 707- 717 ,(1995)
F. Cankat Tulunay, S.B. Sparber, A.E. Takemori, The effect of dopaminergic stimulation and blockade on the nociceptive and antinociceptive responses of mice. European Journal of Pharmacology. ,vol. 33, pp. 65- 70 ,(1975) , 10.1016/0014-2999(75)90139-9
Yu Lin, Thomas J. Morrow, Judith A. Kiritsy-Roy, L. Cass Terry, Kenneth L. Casey, Cocaine: evidence for supraspinal, dopamine-mediated, non-opiate analgesia Brain Research. ,vol. 479, pp. 306- 312 ,(1989) , 10.1016/0006-8993(89)91633-8
C. Suaudeau, J. Costentin, Analgesic effect of the direct D2 dopamine receptor agonist RU 24926 and cross tolerance with morphine Fundamental & Clinical Pharmacology. ,vol. 9, pp. 147- 152 ,(1995) , 10.1111/J.1472-8206.1995.TB00274.X
Jonathan A. Javitch, Robert O. Blaustein, Solomon H. Snyder, [3H]mazindol binding associated with neuronal dopamine uptake sites in corpus striatum membranes. European Journal of Pharmacology. ,vol. 90, pp. 461- 462 ,(1983) , 10.1016/0014-2999(83)90574-5
Fernanda Zambotti, Michelle O. Carruba, Fernando Barzaghi, Lucia Vicentini, Antonio Groppetti, Paolo Mantegazza, Behavioural effects of a new non-phenylethylamine anorexigenic agent : Mazindol☆ European Journal of Pharmacology. ,vol. 36, pp. 405- 412 ,(1976) , 10.1016/0014-2999(76)90094-7
Gudrun H.M. Paalzow, Lennart K. Paalzow, Opposing effects of apomorphine on pain in rats. Evaluation of the dose-response curve. European Journal of Pharmacology. ,vol. 88, pp. 27- 35 ,(1983) , 10.1016/0014-2999(83)90388-6
Adriana Regina Rigon, Reinaldo Naoto Takahashi, The effects of systemic procaine, lidocaine and dimethocaine on nociception in mice General Pharmacology-the Vascular System. ,vol. 27, pp. 647- 650 ,(1996) , 10.1016/0306-3623(95)02079-9
Gabriele Biella, Marco Lacerenza, Paolo Marchettini, Maria Luisa Sotgiu, Diverse modulation by systemic lidocaine of iontophoretic NMDA and quisqualic acid induced excitations on rat dorsal horn neurons. Neuroscience Letters. ,vol. 157, pp. 207- 210 ,(1993) , 10.1016/0304-3940(93)90738-7